✦ LIBER ✦

Celecoxib and Curcumin Synergistically Inhibit the Growth of Colorectal Cancer Cells

✍ Scribed by Lev-Ari, S.

Book ID: 127360422
Publisher: American Association for Cancer Research
Year: 2005
Tongue: English
Weight: 526 KB
Volume: 11
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-05-0171

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Curcumin synergistically augments bcr/ab

Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells

✍ Kun-zhong ZHANG; Jian-hua XU; Xiu-wang HUANG; Li-xian WU; Yu SU; Yuan-zhong CHEN 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 Chinese ⚖ 558 KB

Curcumin synergistically augments bcr/ab

Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells

✍ Zhang, Kun-zhong; Xu, Jian-hua; Huang, Xiu-wang; Wu, Li-xian; Su, Yu; Chen, Yuan 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 Chinese ⚖ 574 KB

Citrus limonoids and curcumin additively

Citrus limonoids and curcumin additively inhibit human colon cancer cells

✍ Chidambara Murthy, Kotamballi N.; Jayaprakasha, G. K.; Patil, Bhimanagouda S. 📂 Article 📅 2013 🏛 The Royal Society of Chemistry 🌐 English ⚖ 629 KB

Celecoxib inhibits growth of tumors in a

Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer

✍ Pieter de Heer; Maro H. Sandel; Gunther Guertens; Gert de Boeck; Margaretha M. K 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 501 KB

Curcumin enhances dasatinib-induced inhi

Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells

✍ Jyoti Nautiyal; Sanjeev Banerjee; Shailender S. Kanwar; Yingjie Yu; Bhaumik B Pa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 817 KB

## Abstract Colorectal cancer is the third most common form of malignancy, behind prostate and lung cancers. Despite recent advances in medicine, mortality from colorectal cancer remains high, highlighting the need for improved therapies. Numerous studies have demonstrated increased activation of E

PPARГ and RXR synergistically inhibit th

PPARГ and RXR synergistically inhibit the expression of cyclin D1 and suppress the growth of pancreatic cancer cells

✍ Miyuki Toyota; Yoshiji Miyazaki; Shinji Kitamura; Yutaka Nagasawa; Shintaro Hira 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 176 KB